Drug Profile
ONO 4053
Alternative Names: ONO-4053Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical
- Class Antiallergics
- Mechanism of Action Prostaglandin D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Allergic rhinitis; Seasonal allergic rhinitis
Most Recent Events
- 21 Sep 2020 No development reported - Phase-II for Allergic rhinitis in Japan (PO)
- 21 Sep 2020 No development reported - Phase-II for Seasonal allergic rhinitis in Austria, Japan (PO)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Allergic-rhinitis(In volunteers) in United Kingdom (PO, Tablet)